Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific δ-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome

Biochemical Pharmacology

Volumn 60, Issue 2, 2000, Pages 275-283

  Suzuki, Tsutomu ^a   Takahashi, Toru ^a   Yamasaki, Akira ^a   Fujiwara, Tadao ^a   Hirakawa, Masahisa ^a   Akagi, Reiko ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

aminolevulinate synthase; Heme; Heme oxygenase 1; Lipopolysaccharide; Multiple organ dysfunction syndrome; Sepsis

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HEME OXYGENASE; HEME OXYGENASE 1; INTERLEUKIN 6; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CATABOLISM; CONTROLLED STUDY; ENZYME REGULATION; FEVER; GENE EXPRESSION; HEME SYNTHESIS; HISTOLOGY; KIDNEY INJURY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER INJURY; LUNG INJURY; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; SEPSIS; TISSUE SPECIFICITY;

5-AMINOLEVULINATE SYNTHETASE; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; MULTIPLE ORGAN FAILURE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEPSIS; TIME FACTORS;

EID: 0034662427     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00324-5     Document Type: Article

References (41)

1. Friedman G., Silva E., Vincent J.L. Has the mortality of septic shock changed with time. Crit Care Med. 26:1998;2078-2086.
2. Sheu J.R., Hung W.C., Wu C.H., Ma M.C., Kan Y.C., Lin C.H., Lin M.S., Luk H.N., Yen M.H. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation. 99:1999;3056-3062.
3. Pedoto A., Tassiopoulos A.K., Oler A., McGraw D.J., Hoffman S.P., Camporesi E.M., Hakim T.S. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide. Crit Care Med. 26:1998;2021-2028.
4. Murphy K., Haudek S.B., Thompson M., Giroir B.P. Molecular biology of septic shock. New Horiz. 6:1998;181-193.
5. Bone R.C. Gram-negative sepsis Background, clinical features, and intervention . Chest. 100:1991;802-808.
6. Zimmerman J.J. Defining the role of oxyradicals in the pathogenesis of sepsis. Crit Care Med. 23:1995;616-617.
7. Basu S., Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett. 438:1998;159-160.
8. Yoshinaga T., Sassa S., Kappas A. A comparative study of heme degradation by NADPH-cytochrome c reductase alone and by the complete heme oxygenase system. J Biol Chem. 257:1982;7794-7802.
9. Shibahara S., Müller R.M., Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem. 262:1987;12889-12892.
10. Mitani K., Fujita H., Kappas A., Sassa S. Heme oxygenase is a positive acute-phase reactant in human Hep3B hepatoma cells. Blood. 79:1992;1255-1259.
11. Alam J., Shibahara S., Smith A. Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem. 264:1989;6371-6375.
12. Keyse S.M., Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA. 86:1989;99-103.
13. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 94:1997;10919-10924.
14. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 94:1997;10925-10930.
15. Camhi S.L., Alam J., Otterbein L., Sylvester S.L., Choi A.M. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol. 13:1995;387-398.
16. Otterbein L., Sylvester S.L., Choi A.M. Hemoglobin provides protection against lethal endotoxemia in rats The role of heme oxygenase-1 . Am J Respir Cell Mol Biol. 13:1995;595-601.
17. Shimizu H., Takahashi T., Suzuki T., Yamasaki A., Fujiwara T., Odaka Y., Hirakawa M., Fujita H., Akagi R. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med. 28:2000;809-817.
18. Odaka Y., Takahashi T., Yamasaki A., Suzuki T., Fujiwara T., Yamada T., Hirakawa M., Fujita H., Ohmori E., Akagi R. Prevention of halothane-induced hepatotoxicity by hemin pretreatment The protective role of heme oxygenase-1 induction . Biochem Pharmacol. 59:2000;871-880.
19. Riddle R.D., Yamamoto M., Engel J.D. Expression of δ-aminolevulinate synthase in avian cells Separate genes encode erythroid-specific and non-specific isoenzyme . Proc Natl Acad Sci USA. 86:1989;792-796.
20. Badawy A.A.-B., Evans M. The regulation of rat liver tryptophan pyrrolase by its cofactor haem Experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms . Biochem J. 150:1975;511-520.
21. Shibahara S., Müller R., Taguchi H., Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA. 82:1985;7865-7869.
22. Cathala G., Savouret J.F., Mendez B., West B.L., Karin M., Martial J.A., Baxter J.D. A method for isolation of intact, translationally active ribonucleic acid. DNA. 2:1983;329-335.
23. Fujita H., Sassa S. The rapid and decremental change in haem oxygenase mRNA during erythroid differentiation of murine erythroleukaemia cells. Br J Haematol. 73:1989;557-560.
24. Feigelson P., Greengard O. A microsomal iron-porphyrin activator of rat liver tryptophan pyrrolase. J Biol Chem. 236:1961;153-157.
25. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 61:1968;748-755.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
27. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 20:1992;864-874.
28. Yamamoto M., Kure S., Engel J.D., Hiraga K. Structure, turnover, and heme-mediated suppression of the level of mRNA encoding rat liver δ-aminolevulinate synthase. J Biol Chem. 263:1988;15973-15979.
29. Schacter B.A., Yoda B., Israels L.G. Cyclic oscillations in rat hepatic heme oxygenase and δ-aminolevulinic acid synthetase following intravenous heme administration. Arch Biochem Biophys. 173:1976;11-17.
30. Granick S., Sinclair P., Sassa S., Grieninger G. Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J Biol Chem. 250:1975;9215-9225.
31. Bissell D.M., Hammaker L.E. Cytochrome P450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys. 176:1976;91-102.
32. Bissell D.M., Hammaker L.E. Cytochrome P-450 heme and the regulation of δ-aminolevulinic acid synthetase in the liver. Arch Biochem Biophys. 176:1976;103-112.
33. Iwasa F., Sassa S., Kappas A. The effects of acute-phase inducers and dimethyl sulphoxide on δ-aminolaevulinate synthase activity in human HepG2 hepatoma cells. Biochem J. 259:1989;605-607.
34. Kikkawa Y., Yano S., Skoza L. Protective effect of interferon inducers against hyperoxic damage. Lab Invest. 50:1984;62-71.
35. Bosch M.A., García R., Pagani R., Portolés M.T., Díaz-Laviada I., Abarca S., Ainaga M.J., Risco C., Municio A.M. Induction of reversible shock by Escherichia coli lipopolysaccharide in rats. Changes in serum and cell membrane parameters. Br J Exp Pathol. 69:1988;805-812.
36. Sewer M.B., Koop D.R., Morgan E.T. Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression. J Pharmacol Exp Ther. 280:1997;1445-1454.
37. Choi A.M., Alam J. Heme oxygenase-1 Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury . Am J Respir Cell Mol Biol. 15:1996;9-19.
38. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., Vercellotti G.M. Endothelial-cell heme uptake from heme proteins Induction of sensitization and desensitization to oxidant damage . Proc Natl Acad Sci USA. 90:1993;9285-9289.
39. Vincent S.H. Oxidative effects of heme and porphyrins on proteins and lipids. Semin Hematol. 26:1989;105-113.
40. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
41. Llesuy S.F., Tomaro M.L. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta. 1223:1994;9-14.